These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 10848881)

  • 1. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.
    Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A polymorphism of the 5' flanking region of tumour necrosis factor α gene is associated with thyroid-associated ophthalmopathy in Japanese.
    Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-764. PubMed ID: 28796351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of tumour necrosis factor alpha (TNF-alpha) polymorphisms with Graves' disease: A meta-analysis.
    Li N; Zhou Z; Liu X; Liu Y; Zhang J; Du L; Wei M; Chen X
    Clin Biochem; 2008 Jul; 41(10-11):881-6. PubMed ID: 18472000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.
    Esteghamati A; Khalilzadeh O; Mobarra Z; Anvari M; Tahvildari M; Amiri HM; Rashidi A; Solgi G; Parivar K; Nikbin B; Amirzargar A
    Eur J Intern Med; 2009 Jul; 20(4):424-8. PubMed ID: 19524188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic approach to the assessment of known TNF-alpha polymorphisms in Graves' disease.
    Simmonds MJ; Heward JM; Howson JM; Foxall H; Nithiyananthan R; Franklyn JA; Gough SC
    Genes Immun; 2004 Jun; 5(4):267-73. PubMed ID: 15057268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relevance of tumor necrosis factor-alpha gene-863C/A polymorphism with thyroid-associated ophthalmopathy].
    Yan SL; Wang YX
    Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):786-90. PubMed ID: 16191343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
    Zhang Q; Yang YM; Lv XY
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis.
    Mrazek F; Holla LI; Hutyrova B; Znojil V; Vasku A; Kolek V; Welsh KI; Vacha J; du Bois RM; Petrek M
    Tissue Antigens; 2005 Feb; 65(2):163-71. PubMed ID: 15713215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
    Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T
    Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
    Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
    Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of vitamin D receptor gene polymorphism with susceptibility to Graves' disease in Eastern Croatian population: case-control study.
    Stefanić M; Karner I; Glavas-Obrovac L; Papić S; Vrdoljak D; Levak G; Krstonosić B
    Croat Med J; 2005 Aug; 46(4):639-46. PubMed ID: 16100768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region.
    Frydecka I; Daroszewski J; Suwalska K; Zołedziowska M; Tutak A; Słowik M; Potoczek S; Dobosz T
    Arch Immunol Ther Exp (Warsz); 2004; 52(5):369-74. PubMed ID: 15507878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
    El-Shabrawi Y; Wegscheider BJ; Weger M; Renner W; Posch U; Ulrich S; Ardjomand N; Hermann J
    Ophthalmology; 2006 Apr; 113(4):695-700. PubMed ID: 16581430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes.
    Date Y; Seki N; Kamizono S; Higuchi T; Hirata T; Miyata K; Ohkuni M; Tatsuzawa O; Yokota S; Joo K; Ueda K; Sasazuki T; Kimura A; Itoh K; Kato H
    Arthritis Rheum; 1999 Dec; 42(12):2577-82. PubMed ID: 10616003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4 gene polymorphism and its association with Graves' disease in the Lebanese population.
    Nakkash-Chmaisse H; Makki RF; Abdelhamid E; Fakhoury H; Salti NN; Salti I
    Eur J Immunogenet; 2004 Jun; 31(3):141-3. PubMed ID: 15182328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
    Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guérin immunotherapy.
    Ahirwar DK; Mandhani A; Dharaskar A; Kesarwani P; Mittal RD
    BJU Int; 2009 Sep; 104(6):867-73. PubMed ID: 19338536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy.
    Khalilzadeh O; Mojazi Amiri H; Tahvildari M; Anvari M; Esteghamati A; Mobarra Z; Tehranchinia Z; Rashidi A; Amirzargar A
    Arch Dermatol Res; 2009 Oct; 301(10):719-23. PubMed ID: 19037649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1*03 is a susceptibility gene in patients with Graves' disease with and without ophthalmopathy.
    Yarman S; Oguz F; Carin M
    Int J Immunogenet; 2007 Feb; 34(1):23-5. PubMed ID: 17284224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF gene polymorphisms in Graves' disease: TNF-308 A/G meta-analysis.
    Kammoun-Krichen M; Bougacha-Elleuch N; Rebai A; Mnif M; Abid M; Ayadi H
    Ann Hum Biol; 2008; 35(6):656-61. PubMed ID: 18989801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.